(More information can be found in Foleys article GLP-1 Drugs: FDA Removes Semaglutide from the Drug Shortage List), The FDA has raised health and safety concerns about these compounded medications, citing issues such as dosing errors, poor inspection records from overseas manufacturers, and, in some instances, adverse events, some of which required medical intervention, These compounded medications are often inaccurately labeled as generic versions of semaglutide and tirzepatide injections and may contain additives, such as vitamins, which have not been approved by the FDA or evaluated through clinical trials, and The FDA has not approved any oral GLP-1 medications, nor has it approved the use of GLP-1 medications for cosmetic purposes
Among the 4,076 participants, 80% were receiving ACE inhibitors, ARBs, or angiotensin receptor-neprilysin inhibitors, and 15.2% were on SGLT2 inhibitors
Both approaches can help with weight loss, but they work in very different ways
The Se in hair often represents the nutritional status of Se in the body over a period of weeks or even months